|
Index of reports
> Cases with Drug Ineffective (30)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Invega (Paliperidone) where reactions include drug ineffective. The selected reports were submitted to the FDA during the sample period of about a year. Reports 1 - 30 of 30 Next >>
Possible Invega side effects in male
Reported by a consumer/non-health professional from Brazil on 2012-08-27
Patient: male, weighing 58.0 kg (127.6 pounds)
Reactions: Drug Ineffective, Suicide Attempt, Albumin Urine Present, Medication Residue
Drug(s) suspected as cause:
Invega
Other drugs received by patient: Bupropion HCL; Clonazepam
Possible Invega side effects in
Reported by a physician from Canada on 2012-08-16
Patient:
Reactions: Hallucination, Auditory, Drug Ineffective, Restlessness, Dizziness, Somnolence
Drug(s) suspected as cause:
Olanzapine
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Invega
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Invega Sustenna
Indication: Product Used FOR Unknown Indication
Invega Sustenna
Possible Invega side effects in 12 year old male
Reported by a physician from United States on 2012-08-08
Patient: 12 year old male
Reactions: Irritability, Swelling Face, Drug Ineffective, Pain in Extremity, Vision Blurred, Headache, Swollen Tongue
Drug(s) suspected as cause:
Invega
Other drugs received by patient: Concerta
Possible Invega side effects in male
Reported by a consumer/non-health professional from United States on 2012-08-06
Patient: male
Reactions: Movement Disorder, Weight Decreased, Drug Ineffective, Pain, Muscle Tightness, Neck Pain, Musculoskeletal Disorder, Adverse Event, Injury, Depression, Muscle Spasms, Back Pain, Inappropriate Schedule of Drug Administration, Dysphagia, Dystonia, Grimacing, Condition Aggravated, Abnormal Behaviour, Torticollis, Muscle Twitching, Dissociation, Suicide Attempt, Disturbance in Attention, Tardive Dyskinesia, Extrapyramidal Disorder, Gait Disturbance, Hypertension
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Risperdal Consta
Start date: 2009-01-01
Risperdal Consta
Dosage: ndc 050468-306
Start date: 2010-04-07
End date: 2011-02-02
Risperdal Consta
Dosage: ndc 050468-306
Indication: Schizophrenia, Paranoid Type
Start date: 2010-04-07
End date: 2011-02-02
Risperdal Consta
Dosage: every 4 to 6 weeks
Start date: 2010-01-01
End date: 2010-01-01
Risperdal Consta
Start date: 2010-04-01
End date: 2010-08-01
Invega
Administration route: Oral
Indication: Schizophrenia, Paranoid Type
Start date: 2008-05-01
End date: 2009-11-01
Risperdal
Administration route: Oral
Indication: Schizophrenia, Paranoid Type
Start date: 2010-07-07
End date: 2011-02-02
Cogentin
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2011-12-11
Risperdal Consta
Indication: Major Depression
Start date: 2010-04-01
End date: 2010-08-01
Risperdal Consta
Dosage: every 4 to 6 weeks
Start date: 2010-01-01
End date: 2010-01-01
Risperdal Consta
Start date: 2010-05-01
End date: 2010-10-01
Zyprexa
Indication: Schizophrenia
Risperdal Consta
Dosage: every 4 to 6 weeks
Start date: 2010-01-01
End date: 2010-01-01
Risperdal Consta
Dosage: ndc 050468-306
Start date: 2010-04-07
End date: 2011-02-02
Risperdal Consta
Indication: Bipolar Disorder
Start date: 2009-01-01
Risperdal Consta
Start date: 2009-01-01
Risperdal Consta
Start date: 2010-05-01
End date: 2010-10-01
Risperdal Consta
Start date: 2010-05-01
End date: 2010-10-01
Risperdal Consta
Start date: 2010-04-01
End date: 2010-08-01
Possible Invega side effects in male
Reported by a consumer/non-health professional from United States on 2012-07-03
Patient: male
Reactions: Weight Decreased, Movement Disorder, Drug Ineffective, Pain, Muscle Tightness, Neck Pain, Musculoskeletal Disorder, Adverse Event, Injury, Depression, Muscle Spasms, Back Pain, Inappropriate Schedule of Drug Administration, Dysphagia, Grimacing, Dystonia, Condition Aggravated, Abnormal Behaviour, Torticollis, Muscle Twitching, Dissociation, Disturbance in Attention, Suicide Attempt, Tardive Dyskinesia, Gait Disturbance, Extrapyramidal Disorder, Hypertension
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Risperdal Consta
Start date: 2010-05-01
End date: 2010-10-01
Risperdal Consta
Start date: 2009-01-01
Risperdal Consta
Start date: 2010-04-01
End date: 2010-08-01
Cogentin
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2011-12-11
Risperdal Consta
Indication: Bipolar Disorder
Start date: 2009-01-01
Risperdal Consta
Dosage: every 4 to 6 weeks
Start date: 2010-01-01
End date: 2010-01-01
Risperdal Consta
Start date: 2010-04-01
End date: 2010-08-01
Risperdal Consta
Dosage: ndc 050468-306
Start date: 2010-04-07
End date: 2011-02-02
Risperdal Consta
Dosage: every 4 to 6 weeks
Start date: 2010-01-01
End date: 2010-01-01
Invega
Administration route: Oral
Indication: Schizophrenia, Paranoid Type
Start date: 2008-05-01
End date: 2009-11-01
Risperdal
Administration route: Oral
Indication: Schizophrenia, Paranoid Type
Start date: 2010-07-07
End date: 2011-02-02
Zyprexa
Indication: Schizophrenia
Risperdal Consta
Start date: 2009-01-01
Risperdal Consta
Start date: 2010-05-01
End date: 2010-10-01
Risperdal Consta
Indication: Major Depression
Start date: 2010-04-01
End date: 2010-08-01
Risperdal Consta
Start date: 2010-05-01
End date: 2010-10-01
Risperdal Consta
Dosage: every 4 to 6 weeks
Start date: 2010-01-01
End date: 2010-01-01
Risperdal Consta
Dosage: ndc 050468-306
Start date: 2010-04-07
End date: 2011-02-02
Risperdal Consta
Dosage: ndc 050468-306
Indication: Schizophrenia, Paranoid Type
Start date: 2010-04-07
End date: 2011-02-02
Possible Invega side effects in female
Reported by a consumer/non-health professional from United States on 2012-07-03
Patient: female, weighing 95.3 kg (209.6 pounds)
Reactions: Abdominal Pain, Tachycardia, Headache, Palpitations, DRY Mouth, Postmenopausal Haemorrhage, Urinary Retention, Crying, Diabetes Mellitus Inadequate Control, Hypotension, Hyperprolactinaemia, Pituitary Tumour, Panic Disorder, Diabetic Coma, Vision Blurred, Electrocardiogram QT Prolonged, Hypersensitivity, Drug Ineffective, Drug Interaction, Disorientation, Constipation, Somnolence, Mania, Abdominal Distension, Dizziness, Decreased Appetite, Vomiting, Nausea, Retching, Muscular Weakness, Amnesia, Renal Failure Chronic, Anxiety, Blood Glucose Decreased, Bipolar Disorder, Eye Swelling, Hypertension
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Invega
Administration route: Oral
Indication: Bipolar Disorder
Start date: 2008-09-01
End date: 2008-09-01
Invega
Administration route: Oral
Start date: 2008-01-01
End date: 2008-01-01
Invega
Administration route: Oral
Indication: Schizophrenia
Start date: 2008-01-01
End date: 2008-01-01
Invega
Administration route: Oral
Start date: 2008-09-01
End date: 2008-09-01
Invega
Administration route: Oral
Start date: 2008-01-01
End date: 2008-01-01
Invega
Administration route: Oral
Start date: 2008-01-01
End date: 2008-01-01
Other drugs received by patient possibly interacting with the suspect drug:
Haldol
Administration route: Oral
Indication: Bipolar Disorder
Start date: 2008-09-26
Haldol
Administration route: Oral
Haldol
Dosage: 5 mg 1 in the am, 5 mg 1 in the pm and 5 mg as needed
Administration route: Oral
Start date: 1976-01-01
Other drugs received by patient: Other Therapeutic Medications; Depakote; Labetalol HCL; Allopurinol; Ibuprofen; Albuterol; Simvastatin; Depakote ER; Prevacid; Acetaminophen; Cozaar; Serevent; Abilify; Clonazepam; Restoril; Benadryl; Flovent; Zyprexa
Possible Invega side effects in male
Reported by a physician from Philippines on 2012-06-26
Patient: male
Reactions: Drug Ineffective, Hypoglycaemia, Urinary Incontinence, Intentional Drug Misuse, Throat Tightness
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Invega
Administration route: Oral
Indication: Schizophrenia
End date: 2012-06-11
Invega Sustenna
Indication: Schizophrenia
Start date: 2012-06-11
Risperdal Consta
Indication: Schizophrenia
End date: 2012-06-11
Glipizide
Dosage: 4 tablets per meal
Indication: Product Used FOR Unknown Indication
Possible Invega side effects in male
Reported by a physician from United States on 2012-06-26
Patient: male
Reactions: Weight Decreased, Movement Disorder, Drug Ineffective, Pain, Muscle Tightness, Neck Pain, Musculoskeletal Disorder, Adverse Event, Injury, Depression, Muscle Spasms, Back Pain, Inappropriate Schedule of Drug Administration, Dysphagia, Grimacing, Dystonia, Abnormal Behaviour, Condition Aggravated, Torticollis, Muscle Twitching, Dissociation, Suicide Attempt, Disturbance in Attention, Gait Disturbance, Extrapyramidal Disorder, Tardive Dyskinesia, Hypertension
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Risperdal Consta
Start date: 2009-01-01
Risperdal Consta
Dosage: every 4 to 6 weeks
Start date: 2010-01-01
End date: 2010-01-01
Risperdal
Administration route: Oral
Indication: Schizophrenia, Paranoid Type
Start date: 2010-07-07
End date: 2011-02-02
Risperdal Consta
Dosage: ndc 050468-306
Start date: 2010-04-07
End date: 2011-02-02
Risperdal Consta
Start date: 2010-04-01
End date: 2010-08-01
Risperdal Consta
Start date: 2009-01-01
Cogentin
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2011-12-11
Risperdal Consta
Indication: Major Depression
Start date: 2010-04-01
End date: 2010-08-01
Invega
Administration route: Oral
Indication: Schizophrenia, Paranoid Type
Start date: 2008-05-01
End date: 2009-11-01
Risperdal Consta
Dosage: every 4 to 6 weeks
Start date: 2010-01-01
End date: 2010-01-01
Risperdal Consta
Dosage: every 4 to 6 weeks
Start date: 2010-01-01
End date: 2010-01-01
Risperdal Consta
Start date: 2010-05-01
End date: 2010-10-01
Risperdal Consta
Dosage: ndc 050468-306
Indication: Schizophrenia, Paranoid Type
Start date: 2010-04-07
End date: 2011-02-02
Risperdal Consta
Start date: 2010-04-01
End date: 2010-08-01
Zyprexa
Indication: Schizophrenia
Risperdal Consta
Indication: Bipolar Disorder
Start date: 2009-01-01
Risperdal Consta
Dosage: ndc 050468-306
Start date: 2010-04-07
End date: 2011-02-02
Risperdal Consta
Start date: 2010-05-01
End date: 2010-10-01
Risperdal Consta
Start date: 2010-05-01
End date: 2010-10-01
Possible Invega side effects in male
Reported by a physician from United States on 2012-06-05
Patient: male
Reactions: Movement Disorder, Weight Decreased, Drug Ineffective, Pain, Muscle Tightness, Neck Pain, Musculoskeletal Disorder, Adverse Event, Depression, Injury, Muscle Spasms, Inappropriate Schedule of Drug Administration, Back Pain, Dysphagia, Dystonia, Grimacing, Condition Aggravated, Abnormal Behaviour, Torticollis, Muscle Twitching, Dissociation, Gait Disturbance, Extrapyramidal Disorder, Tardive Dyskinesia, Hypertension
Drug(s) suspected as cause:
Invega
Administration route: Oral
Indication: Schizophrenia, Paranoid Type
Start date: 2008-05-01
End date: 2009-11-01
Risperdal Consta
Dosage: every 4 to 6 weeks
Start date: 2010-01-01
End date: 2010-01-01
Risperdal Consta
Dosage: ndc 050468-306
Start date: 2010-04-07
End date: 2011-02-02
Risperdal Consta
Dosage: every 4 to 6 weeks
Start date: 2010-01-01
End date: 2010-01-01
Risperdal Consta
Start date: 2010-04-01
End date: 2010-08-01
Risperdal Consta
Start date: 2010-05-01
End date: 2010-10-01
Risperdal
Administration route: Oral
Indication: Schizophrenia, Paranoid Type
Start date: 2010-07-07
End date: 2011-02-02
Cogentin
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2011-12-11
Risperdal Consta
Start date: 2010-05-01
End date: 2010-10-01
Risperdal Consta
Start date: 2009-01-01
Risperdal Consta
Indication: Bipolar Disorder
Start date: 2009-01-01
Risperdal Consta
Start date: 2009-01-01
Risperdal Consta
Start date: 2010-04-01
End date: 2010-08-01
Risperdal Consta
Dosage: ndc 050468-306
Start date: 2010-04-07
End date: 2011-02-02
Risperdal Consta
Dosage: ndc 050468-306
Indication: Schizophrenia, Paranoid Type
Start date: 2010-04-07
End date: 2011-02-02
Risperdal Consta
Indication: Major Depression
Start date: 2010-04-01
End date: 2010-08-01
Risperdal Consta
Dosage: every 4 to 6 weeks
Start date: 2010-01-01
End date: 2010-01-01
Risperdal Consta
Start date: 2010-05-01
End date: 2010-10-01
Zyprexa
Indication: Schizophrenia
Possible Invega side effects in male
Reported by a physician from United States on 2012-05-31
Patient: male
Reactions: Movement Disorder, Weight Decreased, Drug Ineffective, Pain, Muscle Tightness, Neck Pain, Musculoskeletal Disorder, Adverse Event, Depression, Muscle Spasms, Back Pain, Inappropriate Schedule of Drug Administration, Dysphagia, Grimacing, Dystonia, Condition Aggravated, Abnormal Behaviour, Torticollis, Muscle Twitching, Dissociation, Gait Disturbance, Tardive Dyskinesia, Extrapyramidal Disorder, Hypertension
Drug(s) suspected as cause:
Risperdal Consta
Start date: 2010-05-01
End date: 2010-10-01
Risperdal Consta
Start date: 2010-04-01
End date: 2010-08-01
Risperdal Consta
Dosage: every 4 to 6 weeks
Start date: 2010-01-01
End date: 2010-01-01
Risperdal
Administration route: Oral
Indication: Schizophrenia, Paranoid Type
Start date: 2010-07-07
End date: 2011-02-02
Risperdal Consta
Start date: 2010-05-01
End date: 2010-10-01
Invega
Administration route: Oral
Indication: Schizophrenia, Paranoid Type
Start date: 2008-05-01
End date: 2009-11-01
Risperdal Consta
Start date: 2009-01-01
Risperdal Consta
Dosage: every 4 to 6 weeks
Start date: 2010-01-01
End date: 2010-01-01
Risperdal Consta
Dosage: ndc 050468-306
Start date: 2010-04-07
End date: 2011-02-02
Risperdal Consta
Start date: 2010-04-01
End date: 2010-08-01
Risperdal Consta
Start date: 2009-01-01
Zyprexa
Indication: Schizophrenia
Risperdal Consta
Indication: Major Depression
Start date: 2010-04-01
End date: 2010-08-01
Risperdal Consta
Indication: Bipolar Disorder
Start date: 2009-01-01
Risperdal Consta
Dosage: ndc 050468-306
Start date: 2010-04-07
End date: 2011-02-02
Risperdal Consta
Start date: 2010-05-01
End date: 2010-10-01
Cogentin
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2011-12-11
Risperdal Consta
Dosage: every 4 to 6 weeks
Start date: 2010-01-01
End date: 2010-01-01
Risperdal Consta
Dosage: ndc 050468-306
Indication: Schizophrenia, Paranoid Type
Start date: 2010-04-07
End date: 2011-02-02
Possible Invega side effects in female
Reported by a consumer/non-health professional from United States on 2012-05-29
Patient: female, weighing 50.8 kg (111.8 pounds)
Reactions: Drug Ineffective
Drug(s) suspected as cause:
Invega
Administration route: Oral
Start date: 2012-01-01
Invega
Administration route: Oral
Indication: Schizophrenia
Start date: 2011-11-14
End date: 2012-01-01
Other drugs received by patient: Citalopram; Citalopram
Possible Invega side effects in male
Reported by a consumer/non-health professional from United States on 2012-05-23
Patient: male
Reactions: Drug Ineffective
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Invega
Possible Invega side effects in male
Reported by a consumer/non-health professional from United States on 2012-05-15
Patient: male
Reactions: Weight Decreased, Movement Disorder, Drug Ineffective, Pain, Muscle Tightness, Neck Pain, Musculoskeletal Disorder, Adverse Event, Depression, Muscle Spasms, Back Pain, Inappropriate Schedule of Drug Administration, Dysphagia, Dystonia, Grimacing, Abnormal Behaviour, Condition Aggravated, Torticollis, Muscle Twitching, Dissociation, Gait Disturbance, Tardive Dyskinesia, Extrapyramidal Disorder, Hypertension
Drug(s) suspected as cause:
Risperdal Consta
Dosage: every 4 to 6 weeks
Start date: 2010-01-01
End date: 2010-01-01
Risperdal Consta
Start date: 2009-01-01
Risperdal Consta
Indication: Major Depression
Start date: 2010-04-01
End date: 2010-08-01
Risperdal Consta
Dosage: every 4 to 6 weeks
Start date: 2010-01-01
End date: 2010-01-01
Risperdal Consta
Dosage: ndc 050468-306
Start date: 2010-04-07
End date: 2011-02-02
Invega
Administration route: Oral
Indication: Schizophrenia, Paranoid Type
Start date: 2008-05-01
End date: 2009-11-01
Risperdal Consta
Start date: 2010-04-01
End date: 2010-08-01
Zyprexa
Indication: Schizophrenia
Cogentin
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2011-12-11
Risperdal Consta
Start date: 2009-01-01
Risperdal Consta
Dosage: ndc 050468-306
Start date: 2010-04-07
End date: 2011-02-02
Risperdal Consta
Dosage: ndc 050468-306
Indication: Schizophrenia, Paranoid Type
Start date: 2010-04-07
End date: 2011-02-02
Risperdal Consta
Dosage: every 4 to 6 weeks
Start date: 2010-01-01
End date: 2010-01-01
Risperdal Consta
Start date: 2010-05-01
End date: 2010-10-01
Risperdal Consta
Indication: Bipolar Disorder
Start date: 2009-01-01
Risperdal Consta
Start date: 2010-05-01
End date: 2010-10-01
Risperdal Consta
Start date: 2010-04-01
End date: 2010-08-01
Risperdal Consta
Start date: 2010-05-01
End date: 2010-10-01
Risperdal
Administration route: Oral
Indication: Schizophrenia, Paranoid Type
Start date: 2010-07-07
End date: 2011-02-02
Possible Invega side effects in male
Reported by a consumer/non-health professional from United States on 2012-04-27
Patient: male
Reactions: Weight Decreased, Movement Disorder, Drug Ineffective, Pain, Muscle Tightness, Neck Pain, Musculoskeletal Disorder, Adverse Event, Depression, Muscle Spasms, Inappropriate Schedule of Drug Administration, Back Pain, Dysphagia, Dystonia, Grimacing, Abnormal Behaviour, Condition Aggravated, Torticollis, Muscle Twitching, Dissociation, Extrapyramidal Disorder, Gait Disturbance, Tardive Dyskinesia, Hypertension
Drug(s) suspected as cause:
Risperdal Consta
Indication: Major Depression
Start date: 2010-04-01
End date: 2010-08-01
Risperdal Consta
Indication: Bipolar Disorder
Start date: 2009-01-01
Risperdal Consta
Dosage: ndc 050468-306
Indication: Schizophrenia, Paranoid Type
Start date: 2010-04-07
End date: 2011-02-02
Invega
Administration route: Oral
Indication: Schizophrenia, Paranoid Type
Start date: 2008-05-01
End date: 2009-11-01
Zyprexa
Indication: Schizophrenia
Risperdal Consta
Dosage: every 4 to 6 weeks
Start date: 2010-01-01
End date: 2010-01-01
Risperdal Consta
Start date: 2010-05-01
End date: 2010-10-01
Risperdal Consta
Dosage: every 4 to 6 weeks
Start date: 2010-01-01
End date: 2010-01-01
Risperdal Consta
Start date: 2009-01-01
Risperdal Consta
Start date: 2010-04-01
End date: 2010-08-01
Risperdal
Administration route: Oral
Indication: Schizophrenia, Paranoid Type
Start date: 2010-07-07
End date: 2011-02-02
Cogentin
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2011-12-11
Risperdal Consta
Start date: 2010-05-01
End date: 2010-10-01
Risperdal Consta
Start date: 2010-04-01
End date: 2010-08-01
Risperdal Consta
Start date: 2009-01-01
Risperdal Consta
Dosage: ndc 050468-306
Start date: 2010-04-07
End date: 2011-02-02
Risperdal Consta
Dosage: every 4 to 6 weeks
Start date: 2010-01-01
End date: 2010-01-01
Risperdal Consta
Start date: 2010-05-01
End date: 2010-10-01
Risperdal Consta
Dosage: ndc 050468-306
Start date: 2010-04-07
End date: 2011-02-02
Possible Invega side effects in male
Reported by a consumer/non-health professional from United States on 2012-04-23
Patient: male
Reactions: Cataract, Drug Ineffective, Adverse Drug Reaction, Squamous Cell Carcinoma of Skin
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Risperdal
Dosage: began 15 years ago on an unspecified date in 1997
Chlorpromazine
Indication: Hallucination
Risperdal
Start date: 2011-01-01
Risperdal Consta
Indication: Product Used FOR Unknown Indication
Invega
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2005-01-01
End date: 2011-01-01
Risperdal
Dosage: began 15 years ago on an unspecified date in 1997
Indication: Hallucination
Risperdal Consta
Chlorpromazine
Indication: Schizophrenia
Risperdal
Start date: 2011-01-01
Risperdal
Indication: Schizophrenia
Start date: 2011-01-01
Risperdal
Dosage: began 15 years ago on an unspecified date in 1997
Indication: Autism
Other drugs received by patient: Levothyroxine Sodium; Depakote; Diphenhydramine HCL; Fluvoxamine Maleate; Paxil; Benztropine Mesylate; Benztropine Mesylate; Lorazepam
Possible Invega side effects in male
Reported by a consumer/non-health professional from United States on 2012-04-13
Patient: male
Reactions: Drug Ineffective, Abnormal Behaviour
Drug(s) suspected as cause:
Invega
Administration route: Oral
Indication: Schizophrenia, Paranoid Type
Invega Sustenna
Indication: Schizophrenia, Paranoid Type
Start date: 2012-02-03
Possible Invega side effects in male
Reported by a consumer/non-health professional from United States on 2012-04-05
Patient: male
Reactions: Movement Disorder, Weight Decreased, Drug Ineffective, Pain, Muscle Tightness, Neck Pain, Musculoskeletal Disorder, Adverse Event, Depression, Muscle Spasms, Back Pain, Inappropriate Schedule of Drug Administration, Dysphagia, Grimacing, Dystonia, Condition Aggravated, Abnormal Behaviour, Torticollis, Muscle Twitching, Dissociation, Gait Disturbance, Extrapyramidal Disorder, Tardive Dyskinesia, Hypertension
Drug(s) suspected as cause:
Risperdal Consta
Start date: 2010-04-01
End date: 2010-08-01
Risperdal Consta
Start date: 2009-01-01
Risperdal Consta
Dosage: every 4 to 6 weeks
Indication: Bipolar Disorder
Start date: 2010-01-01
End date: 2010-01-01
Risperdal Consta
Start date: 2010-04-01
End date: 2010-08-01
Risperdal Consta
Dosage: ndc 050468-306
Start date: 2010-04-07
End date: 2011-02-02
Risperdal Consta
Start date: 2010-05-01
End date: 2010-10-01
Risperdal Consta
Dosage: every 4 to 6 weeks
Indication: Schizophrenia, Paranoid Type
Start date: 2010-01-01
End date: 2010-01-01
Risperdal Consta
Start date: 2009-01-01
Risperdal Consta
Dosage: ndc 050468-306
Start date: 2010-04-07
End date: 2011-02-02
Risperdal Consta
Start date: 2010-04-01
End date: 2010-08-01
Risperdal
Administration route: Oral
Indication: Schizophrenia, Paranoid Type
Start date: 2010-07-07
End date: 2011-02-02
Risperdal Consta
Dosage: ndc 050468-306
Start date: 2010-04-07
End date: 2011-02-02
Risperdal Consta
Start date: 2009-01-01
Invega
Administration route: Oral
Indication: Schizophrenia, Paranoid Type
Start date: 2008-05-01
End date: 2009-11-01
Risperdal Consta
Dosage: every 4 to 6 weeks
Indication: Major Depression
Start date: 2010-01-01
End date: 2010-01-01
Risperdal Consta
Start date: 2010-05-01
End date: 2010-10-01
Zyprexa
Indication: Schizophrenia
Cogentin
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2011-12-11
Risperdal Consta
Start date: 2010-05-01
End date: 2010-10-01
Possible Invega side effects in male
Reported by a consumer/non-health professional from United States on 2012-03-23
Patient: male, weighing 95.3 kg (209.6 pounds)
Reactions: Weight Decreased, Movement Disorder, Drug Ineffective, Pain, Muscle Tightness, Neck Pain, Musculoskeletal Disorder, Adverse Event, Depression, Muscle Spasms, Back Pain, Inappropriate Schedule of Drug Administration, Dysphagia, Dystonia, Grimacing, Abnormal Behaviour, Condition Aggravated, Torticollis, Muscle Twitching, Dissociation, Gait Disturbance, Tardive Dyskinesia, Hypertension
Drug(s) suspected as cause:
Risperdal Consta
Dosage: every 4 to 6 weeks
Indication: Bipolar Disorder
Start date: 2010-01-01
End date: 2010-01-01
Risperdal Consta
Dosage: every 4 to 6 weeks
Indication: Major Depression
Start date: 2010-01-01
End date: 2010-01-01
Risperdal Consta
Dosage: every 4 to 6 weeks
Indication: Schizophrenia, Paranoid Type
Start date: 2010-01-01
End date: 2010-01-01
Risperdal Consta
Start date: 2009-01-01
Risperdal Consta
Start date: 2010-04-01
End date: 2010-08-01
Risperdal Consta
Start date: 2009-01-01
Zyprexa
Indication: Schizophrenia
Cogentin
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2011-12-11
Risperdal Consta
Dosage: ndc 050468-306
Risperdal Consta
Start date: 2010-04-01
End date: 2010-08-01
Risperdal Consta
Start date: 2010-05-01
End date: 2010-10-01
Risperdal Consta
Dosage: ndc 050468-306
Risperdal Consta
Start date: 2010-04-01
End date: 2010-08-01
Invega
Administration route: Oral
Indication: Schizophrenia, Paranoid Type
Start date: 2008-05-01
End date: 2009-11-01
Risperdal Consta
Dosage: ndc 050468-306
Risperdal Consta
Start date: 2010-05-01
End date: 2010-10-01
Risperdal Consta
Start date: 2009-01-01
Risperdal Consta
Start date: 2010-05-01
End date: 2010-10-01
Possible Invega side effects in male
Reported by a physician from Australia on 2012-02-15
Patient: male
Reactions: Malaise, Drug Ineffective
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Zuclopenthixol
Dosage: depot 200mg/250mg
Indication: Product Used FOR Unknown Indication
Invega Sustenna
Indication: Schizophrenia
Invega
Indication: Schizophrenia
Clozapine
Indication: Product Used FOR Unknown Indication
Invega Sustenna
Clozapine
Possible Invega side effects in female
Reported by a consumer/non-health professional from United States on 2012-02-10
Patient: female, weighing 50.8 kg (111.8 pounds)
Reactions: Drug Ineffective
Drug(s) suspected as cause:
Invega
Administration route: Oral
Indication: Schizophrenia
Start date: 2011-11-14
End date: 2012-01-01
Invega
Administration route: Oral
Start date: 2012-01-01
Other drugs received by patient: Citalopram Hydrobromide; Citalopram Hydrobromide
Possible Invega side effects in
Reported by a physician from Thailand on 2012-02-01
Patient:
Reactions: Drug Ineffective, Depression, Cognitive Disorder
Drug(s) suspected as cause:
Invega
Administration route: Oral
Start date: 2012-01-25
Invega
Administration route: Oral
Invega
Administration route: Oral
Indication: Schizophrenia
Possible Invega side effects in male
Reported by a consumer/non-health professional from United States on 2012-01-13
Patient: male, weighing 72.6 kg (159.7 pounds)
Reactions: Weight Increased, Drug Ineffective, Retrograde Ejaculation
Drug(s) suspected as cause:
Invega Sustenna
Indication: Schizoaffective Disorder
Start date: 2011-09-01
Invega
Administration route: Oral
Indication: Schizoaffective Disorder
Start date: 2012-01-01
Other drugs received by patient: Depakote
Possible Invega side effects in
Reported by a physician from United States on 2012-01-13
Patient:
Reactions: Drug Ineffective
Drug(s) suspected as cause:
Invega
Possible Invega side effects in male
Reported by a consumer/non-health professional from United States on 2012-01-11
Patient: male, weighing 99.8 kg (219.5 pounds)
Reactions: Photosensitivity Reaction, Drug Ineffective, Depression
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Risperdal
Administration route: Oral
Indication: Schizoaffective Disorder
Invega
Dosage: 2 tablets in the morning; 5 tablets bedtime
Administration route: Oral
Start date: 2011-09-01
Geodon
Indication: Schizoaffective Disorder
End date: 2011-01-01
Invega
Administration route: Oral
Indication: Schizoaffective Disorder
Possible Invega side effects in 26 year old female
Reported by a consumer/non-health professional from United States on 2012-01-03
Patient: 26 year old female
Reactions: Fatigue, Drug Ineffective, Increased Appetite, Heart Rate Increased, Insomnia, Anger, Abnormal Loss of Weight, Stress
Drug(s) suspected as cause:
Invega
Administration route: Oral
Start date: 2011-12-22
Invega
Administration route: Oral
Indication: Bipolar I Disorder
Other drugs received by patient: TPN; Bilatin; Flax Seed OIL; Eveninig Primrose OIL; Vitamin D; Horse Chestnut Extract; 5 HTP; Hops
Possible Invega side effects in female
Reported by a physician from United States on 2011-12-28
Patient: female, weighing 95.3 kg (209.6 pounds)
Reactions: Abdominal Pain, Tachycardia, Headache, Palpitations, DRY Mouth, Postmenopausal Haemorrhage, Urinary Retention, Diabetes Mellitus Inadequate Control, Crying, Hypotension, Hyperprolactinaemia, Pituitary Tumour, Panic Disorder, Diabetic Coma, Vision Blurred, Electrocardiogram QT Prolonged, Hypersensitivity, Drug Ineffective, Drug Interaction, Disorientation, Constipation, Somnolence, Mania, Abdominal Distension, Dizziness, Decreased Appetite, Vomiting, Nausea, Retching, Muscular Weakness, Renal Failure Chronic, Amnesia, Blood Glucose Decreased, Anxiety, Bipolar Disorder, Eye Swelling, Hypertension
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Invega
Administration route: Oral
Start date: 2008-01-01
End date: 2008-01-01
Invega
Administration route: Oral
Indication: Bipolar Disorder
Start date: 2008-09-01
End date: 2008-09-01
Invega
Administration route: Oral
Start date: 2008-01-01
End date: 2008-01-01
Invega
Administration route: Oral
Indication: Schizophrenia
Start date: 2008-01-01
End date: 2008-01-01
Invega
Administration route: Oral
Start date: 2008-09-01
End date: 2008-09-01
Invega
Administration route: Oral
Start date: 2008-01-01
End date: 2008-01-01
Other drugs received by patient possibly interacting with the suspect drug:
Haldol
Administration route: Oral
Indication: Bipolar Disorder
Start date: 2008-09-26
Haldol
Administration route: Oral
Haldol
Dosage: 5 mg 1 in the am, 5 mg 1 in the pm and 5 mg as needed
Administration route: Oral
Start date: 1976-01-01
Other drugs received by patient: Restoril; Allopurinol; Acetaminophen; Albuterol; Depakote ER; Ibuprofen; Cozaar; Prevacid; Serevent; Abilify; Zyprexa; Other Therapeutic Medications; Benadryl; Depakote; Flovent; Labetalol HCL; Clonazepam; Simvastatin
Possible Invega side effects in female
Reported by a consumer/non-health professional from United States on 2011-12-23
Patient: female
Reactions: Drug Ineffective
Drug(s) suspected as cause:
Invega Sustenna
Indication: Hallucination, Tactile
Start date: 2011-12-01
Invega
Administration route: Oral
Indication: Hallucination, Tactile
Start date: 2011-12-01
Possible Invega side effects in male
Reported by a consumer/non-health professional from United States on 2011-12-14
Patient: male
Reactions: Drug Ineffective
Drug(s) suspected as cause:
Invega
Dosage: 6mg + 6mg
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2008-01-01
End date: 2011-01-01
Invega
Administration route: Oral
Start date: 2011-01-01
Possible Invega side effects in 51 year old male
Reported by a physician from Switzerland on 2011-10-24
Patient: 51 year old male
Reactions: Drug Ineffective, Libido Decreased, Erectile Dysfunction, Bulimia Nervosa
Drug(s) suspected as cause:
Paliperidone
Indication: Psychotic Disorder
Start date: 2011-09-28
Cymbalta
Administration route: Oral
Indication: Depression
Cymbalta
Administration route: Oral
Indication: Bipolar Disorder
Paliperidone
Start date: 2011-09-20
Invega
Administration route: Oral
Indication: Psychotic Disorder
Start date: 2011-09-01
End date: 2011-09-01
Possible Invega side effects in female
Reported by a consumer/non-health professional from United States on 2011-10-17
Patient: female
Reactions: Drug Ineffective, Incorrect Storage of Drug
Drug(s) suspected as cause:
Invega
Page 1 Next >>
|
